A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)

NCT05596422 · clinicaltrials.gov ↗

COMPLETED

Status

423

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease (IBD)
Ulcerative Colitis
Crohn's Disease

Sponsor

Takeda